国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2013年
8期
698-700
,共3页
慢性鼻窦炎鼻息肉%围手术期%中医药
慢性鼻竇炎鼻息肉%圍手術期%中醫藥
만성비두염비식육%위수술기%중의약
Chronic sinusitis and nasal polyps%Perioperative period%Chinese medicine
目的 探讨鼻通合剂在儿童慢性鼻窦炎鼻息肉围手术期应用对疗效及症状改善的影响.方法 将72例进行功能性鼻内窥镜鼻窦技术的患者,按随机数字表法随机分为治疗组37例、对照组35例.对照组采用常规治疗,治疗组在对照组治疗的基础上配合服用鼻通合剂,观察两组的临床疗效及症状改善情况.结果 ①临床疗效方面:治疗组总有效率在术后3个月、6个月、12个月时分别为94.59％、88.89％、80.00％;对照组分别为88.57％、80.00％、66.67％.两组治疗后同时间段比较,差异均有统计学意义(x2值分别为6.41、6.81、7.22,P＜0.05).治疗组与对照组术后12个月与同组术后3个月比较,差异有统计学意义(x2值分别为6.08、6.98,P＜0.05).②症状积分方面:治疗组患者在治疗后2周、1个月、3个月在缓解头痛[分别为(1.07±0.38)分、(0.79±0.36)分、(0.88±0.32)分]、减少脓涕[分别为(1.29±0.42)分、(1.12±0.38)分、(0.98±061)分]方面与同组术前[分别为(2.38±0.52)分、(2.51±0.60)分]比较,差异有统计学意义(P＜0.01),且疗效优于对照组同时间段[缓解头痛方面分别为(1.54±0.48)分、(1.28±0.58)分、(1.31±0.42)分,减少脓涕方面分别为(1.86±0.56)分、(1.65±0.56)分、(1.32±0.41)分,P＜0.05].治疗组治疗后3个月在改善鼻塞、嗅觉[分别为(1.01±0.51)分、(0.51±0.33)分]方面,分别优于对照组同时间段[分别为(1.52±0.39)分、(0.92±0.34)分,P＜0.05].结论 中医药在儿童慢性鼻窦炎鼻息肉围手术期应用可有效改善症状,提高疗效.
目的 探討鼻通閤劑在兒童慢性鼻竇炎鼻息肉圍手術期應用對療效及癥狀改善的影響.方法 將72例進行功能性鼻內窺鏡鼻竇技術的患者,按隨機數字錶法隨機分為治療組37例、對照組35例.對照組採用常規治療,治療組在對照組治療的基礎上配閤服用鼻通閤劑,觀察兩組的臨床療效及癥狀改善情況.結果 ①臨床療效方麵:治療組總有效率在術後3箇月、6箇月、12箇月時分彆為94.59％、88.89％、80.00％;對照組分彆為88.57％、80.00％、66.67％.兩組治療後同時間段比較,差異均有統計學意義(x2值分彆為6.41、6.81、7.22,P＜0.05).治療組與對照組術後12箇月與同組術後3箇月比較,差異有統計學意義(x2值分彆為6.08、6.98,P＜0.05).②癥狀積分方麵:治療組患者在治療後2週、1箇月、3箇月在緩解頭痛[分彆為(1.07±0.38)分、(0.79±0.36)分、(0.88±0.32)分]、減少膿涕[分彆為(1.29±0.42)分、(1.12±0.38)分、(0.98±061)分]方麵與同組術前[分彆為(2.38±0.52)分、(2.51±0.60)分]比較,差異有統計學意義(P＜0.01),且療效優于對照組同時間段[緩解頭痛方麵分彆為(1.54±0.48)分、(1.28±0.58)分、(1.31±0.42)分,減少膿涕方麵分彆為(1.86±0.56)分、(1.65±0.56)分、(1.32±0.41)分,P＜0.05].治療組治療後3箇月在改善鼻塞、嗅覺[分彆為(1.01±0.51)分、(0.51±0.33)分]方麵,分彆優于對照組同時間段[分彆為(1.52±0.39)分、(0.92±0.34)分,P＜0.05].結論 中醫藥在兒童慢性鼻竇炎鼻息肉圍手術期應用可有效改善癥狀,提高療效.
목적 탐토비통합제재인동만성비두염비식육위수술기응용대료효급증상개선적영향.방법 장72례진행공능성비내규경비두기술적환자,안수궤수자표법수궤분위치료조37례、대조조35례.대조조채용상규치료,치료조재대조조치료적기출상배합복용비통합제,관찰량조적림상료효급증상개선정황.결과 ①림상료효방면:치료조총유효솔재술후3개월、6개월、12개월시분별위94.59％、88.89％、80.00％;대조조분별위88.57％、80.00％、66.67％.량조치료후동시간단비교,차이균유통계학의의(x2치분별위6.41、6.81、7.22,P＜0.05).치료조여대조조술후12개월여동조술후3개월비교,차이유통계학의의(x2치분별위6.08、6.98,P＜0.05).②증상적분방면:치료조환자재치료후2주、1개월、3개월재완해두통[분별위(1.07±0.38)분、(0.79±0.36)분、(0.88±0.32)분]、감소농체[분별위(1.29±0.42)분、(1.12±0.38)분、(0.98±061)분]방면여동조술전[분별위(2.38±0.52)분、(2.51±0.60)분]비교,차이유통계학의의(P＜0.01),차료효우우대조조동시간단[완해두통방면분별위(1.54±0.48)분、(1.28±0.58)분、(1.31±0.42)분,감소농체방면분별위(1.86±0.56)분、(1.65±0.56)분、(1.32±0.41)분,P＜0.05].치료조치료후3개월재개선비새、후각[분별위(1.01±0.51)분、(0.51±0.33)분]방면,분별우우대조조동시간단[분별위(1.52±0.39)분、(0.92±0.34)분,P＜0.05].결론 중의약재인동만성비두염비식육위수술기응용가유효개선증상,제고료효.
Objective To study the effects of Bitong mixture on children with chronic sinusitis and nasal polyp in perioperative period.Methods 72 patients acquired for nasal endoscope were randomly divided into a combining traditional Chinese and western medicine treatment group and a control group.The control group was given traditional western medical treatment,and treatment group was given Bitong mixture on that basis.Results ①clinical effects:Total effective rate of postoperative 3 months、6 months、9 months was 94.59％、88.89％、80.00％ in the treatment group respectively and 88.57％、80.00％、66.67％ in the control group respectively.Compared the two groups after treatment at the same time,differences were statistically significant (x2=6.41 、6.81、7.22,P＜0.05).The efficacy of 12 months after operation in the treatment group and control group declined compared with that of 3 months after operation in each group,but still significant differences existed between groups (x2=6.08、6.98,P＜0.05).②symptom score:symptoms improvements such as alleviating headaches 、reducing pus stuff at 2 weeks 、1 months 、3 months after treatment in the treatment group was obvious than those before the treatment (P＜0.01),and also better than those in the control group at the same time.The improving blocked nose,sense of smell after three months treatment in the treatment group were better than those of the control group respectively at the time(P＜0.05).Conclusion Traditional Chinese medicine can effectively improve symptoms,enhance the curative effect in children with chronic sinusitis and nasal polyp at perioperative period,and it is worth of further clinical application and research.
